Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents
Hepatobiliary Surg Nutr
.
2020 Dec;9(6):777-779.
doi: 10.21037/hbsn.2020.03.04.
Authors
Toshiharu Sakurai
1
,
Naoshi Nishida
1
,
Masatoshi Kudo
1
Affiliation
1
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
PMID:
33299833
PMCID:
PMC7720063
DOI:
10.21037/hbsn.2020.03.04
No abstract available
Publication types
Editorial
Comment